Cargando…

Bimatoprost in the Treatment of Eyelash Universalis Alopecia Areata

OBJECTIVES: To evaluate topical bimatoprost for eyelash growth in patients with alopecia areata (AA). DESIGN: A 1-year retrospective study, bilateral eyelash alopecia. MATERIALS AND METHODS: Forty-one subjects with AA universalis without ocular disease applied 0.03% bimatoprost to the eyelid margin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vila, Teresa Ojeda, Camacho Martinez, Francisco M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107964/ https://www.ncbi.nlm.nih.gov/pubmed/21712909 http://dx.doi.org/10.4103/0974-7753.77511

Ejemplares similares

Bimatoprost in the treatment of eyelash hypotrichosis
por: Law, Simon K
Publicado: (2010)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
por: Anzengruber, Florian, et al.
Publicado: (2016)

Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
por: Craiglow, Brittany G.
Publicado: (2018)

Management of hypotrichosis of the eyelashes: Focus on bimatoprost
por: Fagien, Steven
Publicado: (2010)

Severe Onycholysis in a Card Illusionist with Alopecia Areata Universalis
por: Tosti, Antonella, et al.
Publicado: (2013)

An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
por: Borchert, Mark, et al.
Publicado: (2016)

Alopecia Areata Universalis in the Onset of Autoimmune Polyendocrine Syndrome Type III C
por: Neagu, Nicoleta, et al.
Publicado: (2022)

Bimatoprost for Eyelash Growth in Japanese Subjects: Two Multicenter Controlled Studies
por: Harii, K., et al.
Publicado: (2014)

Clinical Experience with Oral Tofacitinib in a Patient with Alopecia Areata Universalis and Rheumatoid Arthritis
por: Abe, Daniele Tiemi, et al.
Publicado: (2020)

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
por: Mostaghimi, Arash, et al.
Publicado: (2023)

The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: An Analysis of Efficacy and Safety
por: Morris, Carrie L, et al.
Publicado: (2011)

Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2021)

Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
por: Ferreira, Sineida Berbert, et al.
Publicado: (2016)

Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study
por: Sayed, Khulood Muhammad, et al.
Publicado: (2019)

Alopecia areata universalis nach Sitagliptin-Einnahme: Mögliche immunologische Wirkung von Dipeptidylpeptidase-4-Inhibitoren?
por: Kohlmann, Johannes, et al.
Publicado: (2020)

Erratum to: Bimatoprost for Eyelash Growth in Japanese Subjects: Two Multicenter Controlled Studies
por: Harii, K., et al.
Publicado: (2014)

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
por: Kołcz, Kinga, et al.
Publicado: (2023)

Effective treatment of alopecia universalis with oral upadacitinib
por: Youssef, Soundos, et al.
Publicado: (2022)

Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review
por: Abdalla, Hani, et al.
Publicado: (2022)

Alopecia Areata
por: Reid, Thomas
Publicado: (1869)

Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
por: Wyrwich, Kathleen W., et al.
Publicado: (2020)

Eyebrow and Eyelash Alopecia: A Clinical Review
por: Nguyen, Betty, et al.
Publicado: (2022)

Bimatoprost versus Clobetasol Propionate in Scalp Alopecia Areata: A Prospective Non-Randomized Open-Label Clinical Trial
por: Bhusal, Mohan, et al.
Publicado: (2023)

Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
por: Cho, Hyun Hee, et al.
Publicado: (2012)

IS ALOPECIA AREATA PSYCHOSOMATIC ?
por: Devar, J.V.
Publicado: (1983)

Alopecia universalis in a patient with Sheehan's syndrome
por: Bansal, Shivani, et al.
Publicado: (2016)

Alopecia Areata
Publicado: (1908)

Alopecia Areata
por: Spangenthal, Joseph
Publicado: (1898)

Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Alopecia universalis during treatment with leflunomide and adalimumab - Case report()
por: Lazzarini, Rosana, et al.
Publicado: (2014)

Treatment of alopecia universalis with oral alitretinoin: A case report
por: Grenier, Pierre-Olivier, et al.
Publicado: (2017)

Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
por: Call, John E., et al.
Publicado: (2020)

Eyelash Transplantation for the Treatment of Vitiligo Associated Eyelash Leucotrichia
por: Chatterjee, Manas, et al.
Publicado: (2016)

Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
por: Alniemi, Dema T., et al.
Publicado: (2019)

Immunopathogenesis of alopecia areata
por: Olayinka, Jadesola (Jadé) Temitope, et al.
Publicado: (2021)

Management of alopecia areata
por: Harries, M J, et al.
Publicado: (2010)

The Naming of Alopecia Areata
por: Montgomery, Douglass W.
Publicado: (1931)

Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis
por: Riad, Hassan, et al.
Publicado: (2013)

Alopecia Universalis in Polyglandular Autoimmune Syndrome Type I
por: Sardesai, Vidyadhar R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_srsrt32j6i6akb487m3uurer92